biocon-bms-take-insulin-collaboration-to-a-new-level

Biocon, BMS take insulin collaboration to a new level

  • India
  • |
  • News
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Bangalore: Dr Kiran Mazumder Shaw's Biocon, a well-renowned named in the field of insulin, has had a long standing relationship with Bristol-Myers Squibb (BMS) for... Read more

panacea-has-collaborated-extensively-to-strengthen-its-presence-in-us

Panacea expands its footprint in the US

  • India
  • |
  • News
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Panacea Biotec, an Indian firm whose three cardinal business principles have been to focus on innovation, brand building and collaboration, has been extremely committed... Read more

piramal-we-are-here-to-buy

Piramal is on a acquisition spree

  • India
  • |
  • News
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Mumbai: Piramal Enterprises' life sciences division has over a decade history of life sciences-related collaborations with companies from across the globe. The year... Read more

ranbaxy-and-daiichi-sankyo-are-leveraging-on-their-hybrid-business-model-to-expand-their-global-footprint

Ranbaxy uses hybrid model to expand global footprint

  • India
  • |
  • News
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Ranbaxy, like many other Indian firms is leveraging on big pharma's change in strategy from ‘profit alone' model to ‘profit together' model. It is expanding... Read more

india-is-leveraging-on-mncs-need-to-collaborate

India leverages on big pharma's 'profit together' model...

  • India
  • |
  • Analysis
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Charles Darwin had pointed out that "In the long history of humankind (and animal kind, too) those who learned to collaborate and improvise most effectively have... Read more

the-big-question-to-collaborate-or-not-to

Ten top Indian life science collaborations of 2012

  • India
  • |
  • Analysis
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

As the market for new drugs evolves, the methodologies for moving them into the market is changing and becoming more complex. Companies are increasingly relying... Read more

big-pharma-on-a-shopping-spree-to-buy-injectables-firms-especially-in-apac

Why big pharma is busy acquiring injectables firms?

  • India
  • |
  • Analysis
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Big pharma companies are gearing up to combat the shortage of injectables in the US through acquiring companies with approved manufacturing facilities. Last month,... Read more

-l-ms-karen-j-miller-senior-vice-president-corporate-development-and-corporate-communications-and-r-mr-jason-apter-vice-president-and-managing-director-asia-pacifc-sigma-aldrich

Sigma-Aldrich MD: APAC has lion's share in our sales

  • US
  • |
  • Influencers
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Asia Pacific (APAC) has been a region of utmost importance for Sigma-Aldrich (SA) as it has contributed more than 20 percent of global sales last year. Strengthening... Read more

endobarrier-therapy-by-gi-dynamics-gets-biospectrum-asia-pacific-awards-2013-in-the-product-of-the-year-2013-category

EndoBarrier Therapy wins BioSpectrum product award

  • Australia
  • |
  • Influencers
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Diabetes has emerged as a major concern in Asia Pacific and companies are making a beeline to develop treatments for it. ASX-listed GI Dynamics has developed a novel... Read more

dr-sean-simpson-co-founder-cso-lanzatech-gets-biospectrum-asia-pacific-awards-2013-in-the-entrepreneur-of-the-year-2013-category

Green fuel pioneer Sean Simpson wins BioSpectrum award

  • New Zealand
  • |
  • Influencers
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

With the need for green fuel technologies growing bigger every day, New Zealand company LanzaTech is providing an alternative solution to the energy crisis. Stepping... Read more

dr-saleem-mohammad-founder-xcode-life-sciences-india-winner-of-the-biospectrum-asia-pacific-awards-2013-award-in-the-emerging-company-of-the-year-2013-category

Xcode decodes DNA, wins BioSpectrum award

  • India
  • |
  • Influencers
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Dr Saleem Mohammad, who founded XCode Life Sciences in December 2010, first had the idea of starting this company while he was pursuing his PhD in Bioinformatics... Read more

volitionrx-singapore-gets-biospectrum-asia-pacific-awards-2013-in-the-emerging-company-of-the-year-2013-category

Affordable cancer diagnostics wins VolitionRx BioSpectrum...

  • Singapore
  • |
  • Influencers
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Driven by the demand for affordable and simple diagnostics, VolitionRx has been focusing on diagnostic tests for cancer that are as simple and easy-to-use as the... Read more

menafrivac-by-serum-institute-of-india-india-gets-biospectrum-asia-pacific-awards-2013-in-the-product-of-the-year-2013-category

MenAfriVac wins BioSpectrum product award for fight against...

  • India
  • |
  • Influencers
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Neisseria meningitidis (meningococcus) is a cause of the contagious bacterial meningitis that can lead to life-threatening infections in infants, children and young... Read more

mr-sahil-kapoor-one-of-the-founders-of-novo-informatics-india-winner-of-the-biospectrum-asia-pacific-awards-2013-in-the-emerging-company-of-the-year-2013-category

Biopectrum award winner Novo Informatics brings speed to...

  • India
  • |
  • Influencers
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Novo Informatics is the brainchild of a group of students and researchers from the Indian Institute of Technology (IIT), Delhi, a premier academic institution in... Read more

dr-york-zhu-founder-of-biomics-biotechnologies-china-winner-of-the-biospectrum-asia-pacific-awards-2013-in-the-emerging-company-of-the-year-2013-category

BioSpectrum award winner Biomics uses RNAi for therapeutics...

  • China
  • |
  • Influencers
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

Biomics Biotechnologies, China, founded in February 2006, is on road to be counted as one of Asia's leading RNA interference (RNAi) therapeutical technology company.... Read more

Previous 1 3 4 5 6 7

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X